The authors demonstrated that b-GGT increased in non-alcoholic fatty liver disease (NAFLD) but not in chronic hepatitis C (CHC) and that b-GGT/s-GGT ratio showed the highest diagnostic accuracy for distinguishing NAFLD and CHC [39]. This evidence concerns the gene GGT1 and metabolic dysfunction-associated steatotic liver disease.